BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 136 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,583,000 | +4.7% | 317,364 | +3.8% | 0.00% | 0.0% |
Q4 2018 | $2,467,000 | -45.2% | 305,727 | -48.1% | 0.00% | 0.0% |
Q3 2018 | $4,498,000 | +177.3% | 589,572 | +108.3% | 0.00% | +50.0% |
Q2 2018 | $1,622,000 | +25.4% | 283,104 | +4.4% | 0.00% | 0.0% |
Q1 2018 | $1,293,000 | -2.5% | 271,137 | +0.4% | 0.00% | 0.0% |
Q4 2017 | $1,326,000 | +25.3% | 269,999 | +33.7% | 0.00% | +100.0% |
Q3 2017 | $1,058,000 | -3.1% | 201,879 | +2.8% | 0.00% | -50.0% |
Q2 2017 | $1,092,000 | +3.2% | 196,385 | +55.9% | 0.00% | 0.0% |
Q1 2017 | $1,058,000 | +32.9% | 125,947 | +0.1% | 0.00% | +100.0% |
Q4 2016 | $796,000 | +70.1% | 125,777 | +18.5% | 0.00% | 0.0% |
Q3 2016 | $468,000 | +40.5% | 106,162 | -9.6% | 0.00% | 0.0% |
Q2 2016 | $333,000 | +9.9% | 117,398 | +9.7% | 0.00% | 0.0% |
Q1 2016 | $303,000 | -93.0% | 107,034 | -74.4% | 0.00% | -87.5% |
Q4 2015 | $4,315,000 | -9.5% | 418,134 | 0.0% | 0.01% | -20.0% |
Q3 2015 | $4,767,000 | +202.9% | 418,134 | +296.6% | 0.01% | +233.3% |
Q2 2015 | $1,574,000 | +74.1% | 105,420 | +5.3% | 0.00% | +50.0% |
Q1 2015 | $904,000 | -24.3% | 100,074 | +1.9% | 0.00% | 0.0% |
Q4 2014 | $1,194,000 | +24.4% | 98,183 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $960,000 | -23.3% | 98,183 | 0.0% | 0.00% | -33.3% |
Q2 2014 | $1,252,000 | – | 98,183 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 864,916 | $13,674,000 | 13.71% |
Sarissa Capital Management LP | 4,261,000 | $67,366,000 | 5.36% |
ORACLE INVESTMENT MANAGEMENT INC | 1,920,733 | $30,367,000 | 4.18% |
HealthCor Management, L.P. | 3,248,100 | $51,352,000 | 2.05% |
Parkman Healthcare Partners LLC | 351,961 | $5,565,000 | 1.22% |
Bain Capital Public Equity Management II, LLC | 1,560,730 | $24,675,000 | 1.06% |
Baker Brothers Advisors | 12,710,818 | $200,958,000 | 0.88% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,835,000 | $44,821,000 | 0.80% |
Biondo Investment Advisors, LLC | 265,840 | $4,203,000 | 0.72% |
EAM Global Investors LLC | 157,065 | $2,483,000 | 0.69% |